2014
Autoimmune pancreatitis
DITE, Petr; Hana NECHUTOVÁ; Magdalena UVIROVÁ; Jana DVORACKOVA; Bohuslav KIANIČKA et al.Základní údaje
Originální název
Autoimmune pancreatitis
Autoři
DITE, Petr; Hana NECHUTOVÁ; Magdalena UVIROVÁ; Jana DVORACKOVA; Bohuslav KIANIČKA a Arnost MARTINEK
Vydání
Biomedical Papers of the Faculty of Medicine of Palacký University, Olomouc, Czech Republic, Olomouc, Palacky University, 2014, 1213-8118
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30200 3.2 Clinical medicine
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 1.200
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/14:00076556
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
chronic pancreatitis; autoimmune pancreatitis; immunoglobulines; IgG4; steroids; extrapancreatic lesions; pancreatic biopsy
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 23. 9. 2014 13:55, Soňa Böhmová
Anotace
V originále
Introduction. Autoimmune pancreatitis (AIP) is the specific type of chronic pancreatitis due to autoimmune background and mechanism. Characteristics. The main clinical symptoms of AIP are obstructive jaundice and abdominal discomfort. The typical histological findings are lymphocytes and IgG4 plasma cells infiltration, fibrosis and venulitis within pancreatic gland. Plasma level of IgG4 is usually extremely high. Objectives. Diagnosis: High level IgG4 positive plasma cells in serum, lymphoplasmatic infiltration found on histological staining of pancreatic tissue, "sausage-like" pancreas in ultrasound and CT scans, and response to steroid therapy are crucial for making of diagnosis. Classification of AIP: AIP can be classified into two subtypes. Type 1 was recognized as the pancreatic manifestation of multiorgan disorder, called IgG4 related disease. Type 2 is a pancreas-specific disorder not associated with IgG4, with similar histological signs as type 1, but also with the positivity of GEL (granulocythic epithelial lesion). Results. Therapy: Due to its high effectivity in AIP treatment, steroid therapy is the first-line option. The alternative therapy is using immunosuppressants (azathioprine). Recently, there are also first experience in biological therapy already published. Conslusion. Before the start of AIP therapy - the differential diagnosis between pancreatic cancer and AIP is essential.